1. 唐本忠 中国 香港中文大学（深圳） 中国科学院院士 Type I AIE photosensitizers: Mechanism and application
2. 谭蔚泓 中国 上海交通大学 中国科学院院士 Computer-aided design of reversible hybridization chain reaction (CAD-HCR) enables multiplexed singl..
3. Altman, Russ Biagio 美国 Stanford University 2009美国医学院院士 Distinct clinical phenotypes for Crohn's disease derived from patient surveys
4. 赵玉沛 中国 中国医学科学院 中国科学院院士 Mucins in pancreatic cancer: A well-established but promising family for diagnosis, prognosis and th..
5. 卞修武 中国 陆军军医大学 中国科学院院士 Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma
6. 段树民 中国 浙江大学 教授 中国科学院院士 mTOR-mediated metabolic reprogramming shapes distinct microglia functions in response to lipopolysac..
7. Fisher, David E. 美国 Massachusetts General Hospital 2020美国医学院院士 The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promote..
8. 孙颖浩 中国 海军军医大学 中国工程院院士 Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carc..
9. Curran, Tom 美国 Children's Mercy, Kansas City 2009美国医学院院士 Reproducibility of academic preclinical translational research: lessons from the development of Hedg..
10. Michael Karin 美国 University of California, San Diego 2011美国医学院院士;2005美国科学院院士 p62/SQSTM1Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer
11. Majid Ebrahimi,Warkiani 澳大利亚 University of Technology Sydney Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma p..
12. JEAN PAUL THIERY 中国 广州实验室 Circulating tumour cells predict recurrences and survival in head and neck squamous cell carcinoma p..
13. Solomon,Habtemariam 英国 University of Greenwich Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy - A comprehensive r..
14. Javad,Sharifi-Rad 伊朗 SHAHID BEHESHTI UNIVERSITY MEDICAL SCIENCES Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy - A comprehensive r..
15. Matthew J,Ellis 美国 Baylor College of Medicine The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
16. Andrea B,Apolo 美国 National Cancer Institute The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
17. Yair,Lotan 美国 University of Texas Southwestern Medical Center The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
18. Seth P,Lerner 美国 Baylor College of Medicine The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
19. Chad J,Creighton 美国 Baylor College of Medicine The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
20. Jonathan Crawford Irish 加拿大 University of Toronto The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A ..